Vous êtes sur la page 1sur 6

DRUG NAME ACTION INDICATION SIDE NURSING CONSIDERATIONS

EFFECTS

 Generic name: • Bactericidal: inhibits • Neonatal • Dizziness • Monitor patient


• Amikacin Sulfate protein synthesis in sepsis when • Nausea • Arrange for culture and
susceptible strains of other • Vomiting sensitivity testing of infected
 Brand name: gram negative bacteria antibiotics • Loss of area before treatment.
• amikin and the functional cannot be appetite • Monitor duration of treatment.
integrity of bacterial cell used (often • Ensure that patient is well
membrane appears to used in hydrated before and during
be disrupted, causing combination therapy.
cell death. with • Advice patient’s watcher to
penicillin- report changes in baby’s urine
type drug) pattern, difficulty breathing,
rash or skin lesions.
DRUG NAME ACTION INDICATION SIDE EFFECTS NURSING
CONSIDERATIONS

 Generic name: • Bactericidal • Treatment of • Nausea • Check IV site


• Ampicillin action against infections • Vomiting carefully for signs of
Sodium sensitive caused by • GI upset thrombosis or drug
organisms; susceptible • Diarrhea reaction.
 Brand name: inhibits synthesis strains of • Monitor duration of
• Omnipen, of bacterial cell enterococci treatment.
Polycillin, wall, causing cell gram-positive • Advice or inform the
Principen, death. organisms. baby’s watcher to
Totacillin report baby’s
discomfort at IV site,
unusual bleeding or
bruising, mouth
sores, rash, hives,
fever, itching, severe
diarrhea, difficulty
breathing.
DRUG NAME ACTION INDICATION SIDE EFFECTS NURSING
CONSIDERATIONS

 Generic name: • Bactericidal: • Severe • Nausea • Culture site of


• Vancomycin inhibits cell wall staphylococci • Vomiting infection before
chloride synthesis of infections in • GI upset beginning therapy.
susceptible patients who • Diarrhea • This drug is available
 Brand name: organisms, cannot receive in the IV and oral
• vancocin causing cell or have failed to forms.
death. respond to • Do not stop
penicillins and medication without
cephalosporins. notifying health care
provider.
• This drug must be
taken with the full-
prescribed course.
• Watch out for
difficulty voiding,
rash and flushing.
DRUG NAME ACTION INDICATION SIDE EFFECTS NURSING
CONSIDERATIONS
 Generic name: • Inhibition of • To treat serious • Nausea, • Assess vital signs
• Gentamycin bacterial protein infection caused vomiting, and urine output and
Sulfate synthesis: by gram-negative rash, compare to future vital
bactericidal effect. bacteria. tinnitus, signs.
 Brand name: pruritus, • Instruct the mother to
• Garamycin weakness, report side effects
resulting from the
amino glycosides.
• Administer IV slowly
to minimize possibility
of severe
neuromuscular
blockade with
subsequent
development of apnea.
• Instruct the parents
the possible side effect.
DRUG NAME ACTION INDICATION SIDE EFFECTS NURSING
CONSIDERATIONS
 Generic name: • • Used against • Soreness • Shake vial well before
• Hepatitis B infection caused and redness withdrawal of medication.
by Hepatitis B at the • Give IM in anterolateral
virus. Given to all injection site thigh.
infants regardless or a mild • Inject complete content
of HBsAg status of fever, of vial.
mother. swelling • Do not dilute.
warmth, • Have epinephrine
redness and available for allergic
indurations. reactions.
• Monitor newborn’s
temperature post injection
per agency protocol.
• Store product at 35.6 F
-46.4 F or 2 C- 8 C.
• Do not freeze.
• Record lot number,
expiration date, name and
title in chart.
• Inform mother when
repeat doses need to be
given.
DRUG NAME ACTION INDICATION SIDE EFFECTS NURSING
CONSIDERATIONS
 Generic name: • Promotes hepatic • Prophylaxis of • Flushing, • Monitor for side
Phytonadione synthesis of blood hemorrhagic GI upset, effects and adverse
clotting factors II, disease of the pain, reactions.
 Bran VII, IX, X. newborn. swelling and • Advise relative to
d name: tenderness report unusual bleeding
• Vitamin K at injection or bruising.
• Aquamephy site. • Advise relative to
ton inform healthcare
provider of medication
regimen prior to
treatment.
• Emphasize the
importance of laboratory
tests to monitor
coagulation factors.